The Influence of Plasma Fibrinogen and Serum Ferrum on Blood Viscosity in Adamantiades-Behçet’s Disease

  • S. Mineshita
  • L.M. Wang
  • A. Miura
  • S. Umezu
  • Y. Honda
  • T. Satoh
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 528)


Systemic Lupus Erythematosus Blood Viscosity Plasma Fibrinogen Plasma Viscosity Systemic Lupus Erythematosus Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lehner, T., Lavery, E., Smith, R., et al., 1991, Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet’s syndrome. Infect. Immun. 59: 1434–1441.PubMedGoogle Scholar
  2. 2.
    Kabakci, M.C., Yucel, A.E., Saraclar, Y., et al., 1991, Serum total IgE levels in Behçet’s disease. In Behçet’s Disease, Basic and Clinical Aspects (J.D. O’Duffy, and E. Kokmen, eds.), Marcel Decker, New York, pp. 361–364.Google Scholar
  3. 3.
    Turan, B., Gallati, H., Gürler A., et al., 1997, Systemic levels of the T cell regulatory cytokines IL-10 and Il-12 in Behçet’s disease; soluble TNFR-75 as a biological marker of disease activity. J. Rheumatol. 24: 128–132.PubMedGoogle Scholar
  4. 4.
    Wang, L.M., Kitteringham, N., Mineshita, S., et al., 1997, The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behçet’s Disease. Arch. Dermatol. Res. 289: 444–447.CrossRefPubMedGoogle Scholar
  5. 5.
    Wechsler, B., Vidaihel, M, Bousser, M.G., et al., 1991, Cerebral venous thrombosis in Behçet’s disease: Long-term follow-up of 21 cases. In Behçet’s disease, Basic and Clinical Aspects (J.D. O’Duffy, and E. Kokmen, eds.), Marcel Decker, New York, pp. 155–165.Google Scholar
  6. 6.
    Orem, A., Cimsit, G., Deger O., et al., 1999, Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet’s disease. Dermatology 198: 243–246.PubMedGoogle Scholar
  7. 7.
    Nalcaci, M., and Pekcelen, Y., 1998, Antithrombin III, protein C and protein S plasma levels in patients with Behçet’s disease. J. Int. Med. Res. 26: 206–208.PubMedGoogle Scholar
  8. 8.
    Guermazi, S., Hamza, M., and Dellagi, K., 1993, Protein S, thrombosis and Behçet’s disease. In Behcet’s disease (B. Wechsler, and P. Godeau, eds.), Excerpta Medica, Amsterdam, pp. 127–130.Google Scholar
  9. 9.
    Ramalho, P.S., Freitas, J.P., and Martins, R., 1986, Blood vicosity changes in Behçet’s disease. In Recent advances in Behçet’s disease (T. Lehner, and C.G. Barnes, eds.), Royal College of Medicine Services, London, pp. 59.Google Scholar
  10. 10.
    Shimizu, T. (ed.), 1987, Annual report of Behçet’s disease Research Committee of Japan. Teikyo Pubication, Tokyo, pp. 11–17.Google Scholar
  11. 11.
    Qizilbash, N., Jones, L., Warlow C., et al., 1991, Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. Br. Med. J. 303: 605–609.Google Scholar
  12. 12.
    Kannel, W.B., D’Agostino, R.B., and Belanger, A.J., 1992, Update on fibrinogen as a cardiovascular risk factor. Ann. Epidemiol. 2: 457–466.PubMedGoogle Scholar
  13. 13.
    Ernst, E., 1993, The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 100: 1–12.CrossRefPubMedGoogle Scholar
  14. 14.
    Meade, T.W., 1997, Fibrinogen and cardiovascular disease. J. Clin. Pathol. 50: 13–15.PubMedGoogle Scholar
  15. 15.
    Blann, A., Bignell, A., and McCollum, C., 1988, Von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity. Atherosclerosis 139: 317–322.Google Scholar
  16. 16.
    Ford, E.S., and Giles, W.H., 2000, Serum c-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction. Findings from National Health and Nutrition Examination Survey III. J. Clin. Epidemiol. 53: 95–102.CrossRefPubMedGoogle Scholar
  17. 17.
    Held, C., Hjemdahl, P., Wallen, N.H., et al., 2000, Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris — Results from the APSIS study. Atherosclerosis 148: 179–188.CrossRefPubMedGoogle Scholar
  18. 18.
    Reid, H.L., and De Ceulaer, K., 1999, Abnormal plasma and serum viscosity in systemic lupus erythematosus (SLE): a Jamaican study. Clin. Hemorheol. Microcirculation 20: 175–180.Google Scholar
  19. 19.
    Ohshima, S., Tagiguti, K., Tomooka, S., 1998, The effect of felodipine on the hemorheology and haemodynamic of the hypertension patients (Japanese). J. Jpn. Soc. Biorheol. 12: 120–128.Google Scholar
  20. 20.
    Wang, L.M., Yamamoto, T., Kuyama, Y., et al., 1999, The features of blood viscosity in cardiovascular disease (Japanese). J. Jpn. Soc. Biorheol. 13: 35–41.Google Scholar
  21. 21.
    Katsantonis, J., Adler, Y., Orfanos, C.E., et al., 2000, Adamantiades-Behçet’s disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 201: 37–39.CrossRefPubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • S. Mineshita
    • 2
  • L.M. Wang
    • 2
  • A. Miura
    • 2
  • S. Umezu
    • 3
  • Y. Honda
    • 1
  • T. Satoh
    • 4
  1. 1.The Aoyama Metropolitan Officer’s HospitalTokyoJapan
  2. 2.Department of Preventive Medicine, Medical Research InstituteTokyo Medical and Dental UniversityTokyoJapan
  3. 3.Umezu ClinicSaitamaJapan
  4. 4.Department of Internal MedicineTeikyo UniversityTokyoJapan

Personalised recommendations